Patents by Inventor David W. Anderson

David W. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10874749
    Abstract: A composition of matter comprising an adeno-associated virus (AAV) or other human compatible virus, encoding the gene for Sialidase Neu3, B3Galt4, St3Gal2, or combinations thereof, and a neuron specific promoter, wherein the composition is suitable for administration to a patient comprising injecting the AAV or other human compatible virus into the brain by intracranial stereotaxic injunction; wherein the AAV's encoding for the Sialidase Neu3, B3Galt4, St3Gal2, or combinations thereof enhance and/or normalize levels of GM1 in neurons, providing both therapeutic relief and disease modifying effects in specific areas of the brain relevant to particular neurodegenerative diseases.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: December 29, 2020
    Assignee: Thomas Jefferson University
    Inventors: Jay S. Schneider, David W. Anderson
  • Patent number: 10441588
    Abstract: The present disclosure relates to chemical compounds, methods for their discovery, and their therapeutic and research use. In particular, the present disclosure provides compounds as therapeutic agents against bacterial infections (e.g., biofilms). The present disclosure also provides topical formulations for use in methods for treating bacterial infections.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: October 15, 2019
    Assignees: Curators of the University of Missouri, Nanova, Inc.
    Inventors: Hongmin Sun, David W. Anderson, Feng Qi
  • Patent number: 10293946
    Abstract: An airplane is provided. The airplane includes a vapor cycle air conditioning system that receives outside air, a bleed system with at least one port, and an electric fan. A source of outside air when the airplane is on ground is forced air from the electric fan. The source of the outside air when the airplane is at cruise is bleed air from the at least one port.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: May 21, 2019
    Assignee: HAMILTON SUNDSTRAND CORPORATION
    Inventors: Louis J. Bruno, Thomas M. Zywiak, David W. Anderson, Todd A. Spierling
  • Publication number: 20180214573
    Abstract: A composition of matter comprising an adeno-associated virus (AAV) or other human compatible virus, encoding the gene for Sialidase Neu3, B3Galt4, St3Gal2, or combinations thereof, and a neuron specific promoter, wherein the composition is suitable for administration to a patient comprising injecting the AAV or other human compatible virus into the brain by intracranial stereotaxic injunction; wherein the AAV's encoding for the Sialidase Neu3, B3Galt4, St3Gal2, or combinations thereof enhance and/or normalize levels of GM1 in neurons, providing both therapeutic relief and disease modifying effects in specific areas of the brain relevant to particular neurodegenerative diseases.
    Type: Application
    Filed: July 21, 2016
    Publication date: August 2, 2018
    Applicant: THOMAS JEFFERSON UNIVERSITY
    Inventors: David W. Anderson, Jay S. Schneider
  • Publication number: 20180171431
    Abstract: A method of estimating an unknown solvus for a phase of a given alloy includes providing empirical data of a plurality of alloys from an alloy class, the empirical data at least including chemical compositions, heating rates, cooling rates and alloy solvus temperatures of the plurality of alloys, providing an alloy chemical composition, a selected heating rate and a selected cooling rate of another alloy from the alloy class that has an unknown solvus temperature, estimating the unknown solvus temperature based upon the empirical data to provide an estimated solvus temperature of the alloy, and establishing a solution heat treatment temperature corresponding to the estimated solvus temperature at which to treat a component that includes the alloy.
    Type: Application
    Filed: February 7, 2018
    Publication date: June 21, 2018
    Inventors: Chris Vargas, Eric A. Hansen, Raymond C. Benn, Daniel A. Bales, Ivan M. Schmidt, David W. Anderson, David Ulrich Furrer, William F. Matzke
  • Publication number: 20180042928
    Abstract: The present disclosure relates to chemical compounds, methods for their discovery, and their therapeutic and research use. In particular, the present disclosure provides compounds as therapeutic agents against bacterial infections (e.g., biofilms). The present disclosure also provides topical formulations for use in methods for treating bacterial infections.
    Type: Application
    Filed: September 21, 2017
    Publication date: February 15, 2018
    Inventors: Hongmin Sun, David W. Anderson, Feng Qi
  • Patent number: 9814719
    Abstract: The present disclosure relates to chemical compounds, methods for their discovery, and their therapeutic and research use. In particular, the present disclosure provides compounds as therapeutic agents against bacterial infections (e.g., biofilms). The present disclosure also provides compounds as therapeutic agents in methods for treating pneumonia, methods for reducing bacterial virulence, methods for treating a bacterial wound infection, and methods for treating a urinary tract infection. The present disclosure also provides methods for treating a bacterial infection, wherein the bacterial infection has or is suspected of having an antibiotic-resistant bacteria. The present disclosure also provides surfaces coated with the chemical compounds disclosed herein.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: November 14, 2017
    Assignee: Curators of the University of Missouri
    Inventors: Hongmin Sun, David W. Anderson, Lianhai Li
  • Patent number: 9597170
    Abstract: A totally implantable method for occluding the urethra or bladder neck utilizing an occlusive cuff connected to a control mechanism via a conduit tube. The occlusive cuff is reversibly changed from an activated (occlusive condition) to a deactivated (non-occlusive) condition by depressing a deactivation button contained within a resilient, elastomeric sheath surrounding the control mechanism. The occlusive condition is once again obtained by depressing an activation button also situated within the resilient sheath. In the occlusive condition, a preset tension is applied to a flexible diaphragm through a tensioning suture by a constant force spring contained within the control mechanism. This tension is translated into an occlusive pressure applied to the urethra or bladder neck sufficient to prevent urinary leakage.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: March 21, 2017
    Assignee: GT Urological, LLC
    Inventors: David W. Anderson, Bernard J. Esarey
  • Publication number: 20170056405
    Abstract: The present disclosure relates to chemical compounds, methods for their discovery, and their therapeutic and research use. In particular, the present disclosure provides compounds as therapeutic agents against bacterial infections (e.g., biofilms). The present disclosure also provides compounds as therapeutic agents in methods for treating pneumonia, methods for reducing bacterial virulence, methods for treating a bacterial wound infection, and methods for treating a urinary tract infection. The present disclosure also provides methods for treating a bacterial infection, wherein the bacterial infection has or is suspected of having an antibiotic-resistant bacteria. The present disclosure also provides surfaces coated with the chemical compounds disclosed herein.
    Type: Application
    Filed: October 26, 2016
    Publication date: March 2, 2017
    Inventors: Hongmin Sun, David W. Anderson, Lianhai Li
  • Patent number: 9532847
    Abstract: A package system for a medical device is disclosed. The package system may include a first part and a second part, where a holding platform can be incorporated into the first part of the package system and a collection tray can be incorporated into the second part of the package system. The first part may include leg portions. The leg portions of the first part can be folded and fitted into matching pockets of the second part, so that the first part of the package system can provided a relatively elevated and stable holding platform to hold the medical device. The package system can contain the medical device in the package system in a storage state, and hold the medical device with the holding platform in an application state.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: January 3, 2017
    Assignee: GT Urological, LLC
    Inventors: David L. Hendrickson, David W. Anderson
  • Publication number: 20160355271
    Abstract: An airplane is provided. The airplane includes a vapor cycle air conditioning system that receives outside air, a bleed system with at least one port, and an electric fan. A source of outside air when the airplane is on ground is forced air from the electric fan. The source of the outside air when the airplane is at cruise is bleed air from the at least one port.
    Type: Application
    Filed: June 8, 2016
    Publication date: December 8, 2016
    Inventors: Louis J. Bruno, Thomas M. Zywiak, David W. Anderson, Todd A. Spierling
  • Publication number: 20160220341
    Abstract: A totally implantable method for occluding the urethra or bladder neck utilizing an occlusive cuff connected to a control mechanism via a conduit tube. The occlusive cuff is reversibly changed from an activated (occlusive condition) to a deactivated (non-occlusive) condition by depressing a deactivation button contained within a resilient, elastomeric sheath surrounding the control mechanism. The occlusive condition is once again obtained by depressing an activation button also situated within the resilient sheath. In the occlusive condition, a preset tension is applied to a flexible diaphragm through a tensioning suture by a constant force spring contained within the control mechanism. This tension is translated into an occlusive pressure applied to the urethra or bladder neck sufficient to prevent urinary leakage.
    Type: Application
    Filed: February 2, 2016
    Publication date: August 4, 2016
    Inventor: David W. ANDERSON
  • Patent number: 9301824
    Abstract: A totally implantable method for occluding the urethra or bladder neck utilizing an occlusive cuff connected to a control mechanism via a conduit tube. The occlusive cuff is reversibly changed from an activated (occlusive condition) to a de-activated (non-occlusive) condition by depressing a deactivation button contained within a resilient, elastomeric sheath surrounding the control mechanism. The occlusive condition is once again obtained by depressing an activation button also situated within the resilient sheath. In the occlusive condition, a preset tension is applied to a flexible diaphragm through a tensioning suture by a constant force spring contained within the control mechanism. This tension is translated into an occlusive pressure applied to the urethra or bladder neck sufficient to prevent urinary leakage.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: April 5, 2016
    Assignee: GT Urological, LLC
    Inventors: David W. Anderson, Bernard J. Esarey
  • Publication number: 20160082026
    Abstract: A transmucosal formulation comprising a ganglioside and a mucosal absorption enhancer, as well as a method of treating or preventing Parkinson's disease in a human patient in need thereof comprising parenterally administering such a transmucosal formulation to said patient.
    Type: Application
    Filed: June 1, 2015
    Publication date: March 24, 2016
    Inventors: Jay S. Schneider, John J. Koleng, Robert Florentine, David W. Anderson
  • Publication number: 20150283158
    Abstract: A transmucosal formulation comprising a ganglioside and a mucosal absorption enhancer, as well as a method of treating or preventing Parkinson's disease in a human patient in need thereof comprising parenterally administering such a transmucosal formulation to said patient.
    Type: Application
    Filed: October 21, 2014
    Publication date: October 8, 2015
    Inventors: John J. Koleng, Robert Florentine, David W. Anderson, David W. Anderson
  • Publication number: 20150045609
    Abstract: A totally implantable method for occluding the urethra or bladder neck utilizing an occlusive cuff connected to a control mechanism via a conduit tube. The occlusive cuff is reversibly changed from an activated (occlusive condition) to a deactivated (non-occlusive) condition by depressing a deactivation button contained within a resilient, elastomeric sheath surrounding the control mechanism. The occlusive condition is once again obtained by depressing an activation button also situated within the resilient sheath. In the occlusive condition, a preset tension is applied to a flexible diaphragm through a tensioning suture by a constant force spring contained within the control mechanism. This tension is translated into an occlusive pressure applied to the urethra or bladder neck sufficient to prevent urinary leakage.
    Type: Application
    Filed: August 6, 2014
    Publication date: February 12, 2015
    Inventors: David W. Anderson, Bernard J. Esarey
  • Publication number: 20150021221
    Abstract: A package system for a medical device is disclosed. The package system may include a first part and a second part, where a holding platform can be incorporated into the first part of the package system and a collection tray can be incorporated into the second part of the package system. The first part may include leg portions. The leg portions of the first part can be folded and fitted into matching pockets of the second part, so that the first part of the package system can provided a relatively elevated and stable holding platform to hold the medical device. The package system can contain the medical device in the package system in a storage state, and hold the medical device with the holding platform in an application state.
    Type: Application
    Filed: July 16, 2014
    Publication date: January 22, 2015
    Inventors: David L. Hendrickson, David W. Anderson
  • Publication number: 20140309179
    Abstract: A method of treating or preventing a retinopathy such as glaucoma in a human patient in need thereof comprising administering one or more gangliosides to the patient.
    Type: Application
    Filed: April 17, 2014
    Publication date: October 16, 2014
    Applicant: LZ Therapeutics, Inc.
    Inventors: Jay S. Schneider, Gerri Henwood, Robert Florentine, David W. Anderson
  • Patent number: 8753363
    Abstract: An implantable vessel occlusive device and method for occluding a vessel are described, for example to occlude the urethra or bladder neck. The devices and methods described utilize an occlusive member connected to a control mechanism. The occlusive member is reversibly changed from a non-occlusive condition to an occlusive condition, for example by depressing an activation button contained within a resilient, elastomeric cover surrounding the control mechanism. In the occlusive position, an initial tension is applied to the occlusive member through a tensioning suture. The tension is translated into an occlusive pressure applied to the urethra or bladder neck that is sufficient to prevent urinary leakage. The non-occlusive position can be obtained by depressing the de-activation button. The occlusive member is constructed to allow elution of drugs, such as may be required to combat infection or tissue encapsulation from its surface.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: June 17, 2014
    Assignee: GT Urological, LLC
    Inventors: David W. Anderson, Bernard J. Esarey, Gerald W. Timm
  • Patent number: 8749230
    Abstract: Methods and systems are provided for measuring a thickness of an object. A first portion of a device is positioned on a first side of the object, and a second portion of the device is positioned on an opposite side of the object. The first portion includes at least one first mount and at least one eddy current sensor coupled to the first mount. The second portion includes at least one second mount and at least one target coupled to the second mount. The first mount is magnetically coupled to the second mount such that the eddy current sensor is oriented to interact with the target to enable the thickness of the object to be measured.
    Type: Grant
    Filed: October 13, 2010
    Date of Patent: June 10, 2014
    Assignee: The Boeing Company
    Inventors: Michael D. Fogarty, William J. Tapia, Gary E. Georgeson, Martin L. Freet, Jeffrey G. Thompson, David W. Anderson, Ronald E. VonWahlde